Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. - Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M (Annals of the rheumatic diseases, 2008)